Altimmune Inc
Stock Chart, Company Information, and Scan Results
$3.27(as of Sep 21, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Altimmune Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$3.27
Ticker SymbolALT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees57
CountyUSA
Market Cap$632.2M
EBIDTA-98.6M
P/E Ratio-6.61
Forward P/E Ratio8.18
Earnings per Share-0.76
Profit MarginUnknown
RSI55.70
Shares Outstanding194.5M
ATR0.13
52-Week High6.44
Volume3,515,229
52-Week Low2.56
Book Value474.2M
P/B Ratio1.28
Upper Keltner3.54
P/S Ratio19,561.32
Lower Keltner2.94
Next Earnings Date11/05/2026
Cash Surplus50.5M
Next Ex-Dividend DateUnknown
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Altimmune Inc In Our Stock Scanner
As of Sep 21, 2026
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.